Search
Now showing items 1-3 of 3
Treatment of neoplastic disease with oral interferon
(United States. Patent and Trademark Office, 1998-10-20)
Neoplastic diseases are treated by the administration of human interferon, particularly IFN-α, at a dosage of from about 0.01 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and ...
Treatment of immuno-resistant disease with low-dose interferon
(United States. Patent and Trademark Office, 1991-05-28)
Neoplastic disease, hyperallergenicity, autoimmune disorders characterized by chronic tissue degenerative inflammation and immuno-resistant viral infections are treated by the administration of interferon at a dosage of ...
Treatment of autoimmune disorders with oral interferon
(United States. Patent and Trademark Office, 1998-12-08)
Autoimmune disorders are treated by the administration of human interferon, particularly IFN-α or IFN-β, at a dosage of from about 0.01 to about 5 IU/lb./day such that the interferon is held in contact with the patient's ...